|
J Biol Chem, Vol. 275, Issue 18, 13266-13274, May 5, 2000
Epithelial Sodium Channels Regulate Cystic Fibrosis Transmembrane
Conductance Regulator Chloride Channels in Xenopus
Oocytes*
Qinshi
Jiang §,
Jinqing
Li §,
Rachael
Dubroff ,
Yoon J.
Ahn §,
J. Kevin
Foskett¶,
John
Engelhardt , and
Thomas R.
Kleyman ¶**
From the Departments of Medicine and
¶ Physiology, University of Pennsylvania and Veterans
Affairs Medical Center, Philadelphia, Pennsylvania 19104-6144 and the
Department of Anatomy, University of Iowa,
Iowa City, Iowa 52242
 |
ABSTRACT |
The cystic fibrosis transmembrane conductance
regulator (CFTR), in addition to its well defined
Cl channel properties, regulates other ion
channels. CFTR inhibits epithelial Na+ channel (ENaC)
currents in many epithelial and nonepithelial cells. Because modulation
of net NaCl reabsorption has important implications in extracellular
fluid volume homeostasis and airway fluid volume and composition, we
investigated whether this regulation was reciprocal by examining
whether ENaC regulates CFTR. Co-expression of human (h) CFTR and mouse
(m)   ENaC in Xenopus oocytes resulted in a
significant, 3.7-fold increase in whole-cell hCFTR Cl
conductance compared with oocytes expressing hCFTR alone. The forskolin/3-isobutyl-1-methylxanthine-stimulated whole-cell conductance in hCFTR-mENaC co-injected oocytes was amiloride-insensitive, indicating an inhibition of mENaC following hCFTR activation, and it
was blocked by DPC (diphenylamine-2-carboxylic acid) and was DIDS
(4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid)-insensitive. Enhanced hCFTR Cl conductance was also observed when
either the - or -subunit of mENaC was co-expressed with hCFTR,
but this was not seen when CFTR was co-expressed with the -subunit
of mENaC. Single Cl channel analyses showed that both
CFTR Cl channel open probability and the number of CFTR
Cl channels detected per patch increased when hCFTR was
co-expressed with   mENaC. We conclude that in addition to
acting as a regulator of ENaC, CFTR activity is regulated by ENaC.
 |
INTRODUCTION |
Epithelial cell layers are organized with discrete apical and
basolateral plasma membrane domains that differ in protein composition. This polarized distribution of proteins at the cell surface allows for
the transport of solutes across an epithelial cell layer in a directed,
or vectorial, manner (1, 2). The transport of Na+ and
Cl across an epithelial cell layer may result in the
reabsorption or the secretion of solute. Epithelial Na+
channels (ENaCs)1 are
expressed on the apical membrane of selected epithelia that transport
NaCl in an absorptive manner (3, 4). Activation of ENaC will result in
increased rates of transepithelial NaCl reabsorption. Cl
is transported across absorptive epithelia via paracellular or transcellular pathways. ENaCs are found in epithelial cells lining the
distal nephron (5-7), airway, and alveolar epithelia in the lung
(8-10), and distal colon (7, 10) and have a key role in the regulation
of urinary Na+ reabsorption, extracellular fluid volume
homeostasis, and control of blood pressure.
Several distinct epithelial Cl channels are expressed in
apical plasma membranes of secretory epithelia. These channels
facilitate active Cl secretion (11). Na+ is
transported across secretory epithelia via paracellular pathways. Mutations in an epithelial, cAMP-regulated Cl channel,
the cystic fibrosis transmembrane conductance regulator (CFTR), are
responsible for the cystic fibrosis (CF) phenotype (12-14). As
expected with mutations that lead to a loss of function of secretory
Cl channels, reduced epithelial secretions of NaCl in the
airway, gastrointestinal tract, and certain exocrine organs results in changes in the viscosity of fluids which are a hallmark of cystic fibrosis (15).
Certain hormones that activate CFTR through a protein kinase A-mediated
pathway have also been reported to activate ENaCs (16-18). Whereas
activation of CFTR in secretory epithelia will result in net NaCl
secretion, activation of ENaC in absorptive epithelia will result in
NaCl reabsorption. Selected epithelial cells, including those found in
the airway, distal nephron, and sweat ducts, express both apical
membrane ENaCs as well as CFTR. Activation of CFTR in these cells
appears to be associated with Cl reabsorption (19-22).
In this setting, activation of both CFTR and ENaC might result in
dramatic increases in NaCl entry into cells and associated cell
swelling. Under these circumstances, mechanisms to modulate NaCl entry
are required to avoid large shifts in cell volume. Several groups,
including ours, have demonstrated in selected epithelial as well as
nonepithelial cell types that activation of CFTR is associated with an
inhibition of ENaCs (23-29). This interaction provides a means by
which epithelial cells that express both CFTR and ENaC can modulate net
NaCl entry. CFTR inhibits Na+ channel open probability (16,
24, 30), although the mechanism(s) underlying this inhibition have not
been clearly defined. In contrast, CFTR expression in sweat duct is
required for activation of ENaC by cAMP-dependent protein
kinase-mediated mechanisms (31). Given the importance of the
coordinate regulation of apical plasma membrane Na+ and
Cl channels, we examined whether ENaCs regulate CFTR. Our
results demonstrate that forskolin and 3-isobutyl-1-methylxanthine
(IBMX)-stimulated CFTR Cl currents are increased
significantly in the presence of ENaC, suggesting that ENaCs regulate
CFTR.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Reagents were purchased from vendors listed below
or from Sigma Chemical Co.
Expression of hCFTR and mENaC in Xenopus Oocytes--
Human CFTR
and mouse -, -, and ENaC cRNAs (32) were prepared using a cRNA
synthesis kit (m-MESSAGE mMACHINE, Ambion Inc., Austin, TX). cRNA
concentrations were measured spectroscopically, and the amounts of cRNA
injected into oocytes are indicated under "Results" or in figure
legends. Adult female Xenopus laevis were obtained from
NASCO (Fort Atkinson, WI) and Xenopus-1 (Ann Arbor, MI).
Oocytes were isolated and defolliculated by collagenase treatment. Oocytes were then placed in SOS (100 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, pH 7.6)
supplemented with 2.5 mM sodium pyruvate and 50 µg/ml
gentamycin at 16 °C. Whole-cell current measurements were made 2 days after cRNA injection using the two-electrode voltage clamp method.
Single oocytes were placed in a 1-ml chamber containing modified ND96
(96 mM NaCl, 1 mM KCl, 0.2 mM
CaCl2, 5.8 mM MgCl2, 10 mM Hepes, pH 7.2, by NaOH), connected to a reference bath
electrode by a 3 M KCl-agar bridge. Conventional
two-electrode voltage clamp was performed at room temperature using an
OC-725C oocyte clamp amplifier (Warner Instrument Corp., Hamden, CT)
connected to a PowerMac 7100 via an ITC-16 interface (Instrutech Corp., Great Neck, NY). Pulse+PulseFit software (HEKA elektronik, Lambrecht, Germany) was used to ramp the applied transmembrane potential (Vm) at 10-s intervals from 60 to 60 mV (with
reference to the bath) at a rate of 16 mV/s. Vm
was clamped at the prestimulation reversal potential between the
voltage ramps. Transmembrane current (I) and
Vm were digitized at 200 Hz during the voltage
ramps and recorded directly onto a hard disk. To reduce signal noise, a fifth-order polynomial was fitted to the raw
I-Vm curve from each voltage ramp.
Ion replacement studies were performed by replacing NaCl in the ND96
solution either with N-methyl-D-glucamine (NMDG) Cl to produce a Na+-free extracellular environment or with
Na+ methanesulfonate to produce a
Cl -free extracellular environment. The differences in the
whole-cell conductance measured in the presence and in the absence of
100 µM amiloride were used to define the
amiloride-sensitive Na+ conductance that is carried by
ENaC. Activation of CFTR was accomplished by perfusion of the oocyte
with buffers supplemented with 100 µM IBMX and 10 µM forskolin for 30 min. In all experiments, CFTR Cl conductance was defined as the difference in
conductance measured 30 min after perfusion with 10 µM
forskolin and 100 µM IBMX (forskolin/IBMX) and the
conductance measured prior to forskolin/IBMX stimulation. When
indicated, 50 µM DPC or 200 µM DIDS was
added to the perfusion buffer. The whole-cell conductance and reversal
potential (Erev) were evaluated from the slope
and x intercept, respectively, of the background-corrected
I-Vm curve using Igor Pro software
(WaveMetrics, Lake Oswego, OR). Whole-cell currents were measured at
50 mV. Single channel recordings were performed in the cell-attached configuration. Pipette and bath solutions were Na+-free and
contained (in mM): 96 NMDG Cl, 1 KCl, 0.2 CaCl2, 5.8 MgCl2, 10 Hepes, pH adjusted to 7.2 with NMDG. Electrical signals were amplified using a Dagan PC-one
amplifier (Dagan, Minneapolis, MN), digitized by DigiData 1200 (Axon
Instruments, Foster City, CA), and stored on disk. Pclamp7 (Axon
Instruments) was used for data acquisition and analysis. All data were
collected at room temperature and were filtered at 300 Hz. Closed
states of less than 20 ms and open states of less than 50 ms were
ignored in analyses of open probability. Continuous recording of
greater than 6-min duration with a minimum of 50 opening events was
used to determine open probability and the number of channels within a
patch. Recordings were performed between 30 min and 3 h after stimulation with 10 µM forskolin and 100 µM
IBMX.
 |
RESULTS |
Expression of hCFTR and mENaC in Xenopus Oocytes--
The
Xenopus oocyte expression system was used to examine the
functional expression of hCFTR and   mENaC because this system readily allows for the expression and detection of a variety of exogenous ion channels at the oocyte plasma membrane. Oocytes injected
with 10 ng of hCFTR cRNA were bathed in a solution containing 10 µM forskolin and 100 µM IBMX to activate
endogenous protein kinase A and hCFTR. Whole-cell conductance was
monitored by two-electrode voltage clamp (Fig.
1A). An 11-fold increase in
whole-cell conductance, from 6.5 ± 1.5 µS to 73 ± 8 µS
was observed in response to the addition of forskolin and IBMX (Fig.
1B, n = 38, p < 0.01). No forskolin/IBMX-activated conductance was observed in water-injected oocytes (data not shown).

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 1.
Functional expression of hCFTR in
Xenopus oocytes. Whole-cell conductances were
determined in oocytes injected with 10 ng of hCFTR cRNA prior to
( Fsk/IBMX; control) and after (+Fsk/IBMX) maximum stimulation with 10 µM forskolin and 100 µM IBMX. Panel
A shows a representative response of whole-cell conductance to
activation of hCFTR with forskolin and IBMX. In panel B are
representative current tracings obtained from the voltage ramp protocol
which were used to determine whole-cell conductances. Broken
line, control; solid line, +Fsk/IBMX. No change in
whole-cell conductance was observed in response to forskolin and IBMX
in water-injected oocytes (not shown). The average change in whole-cell
conductance in hCFTR cRNA-injected oocytes 30 min after stimulation
with forskolin/IBMX is shown in panel C. Data are expressed
as the mean ± S.E. (n = 38). An 11-fold increase
in whole-cell conductance, from 6.5 ± 1.5 µS ( Fsk/IBMX) to
73 ± 8 µS (+Fsk/IBMX) was observed in response to forskolin and
IBMX.
|
|
We previously isolated and characterized cDNAs encoding the -,
-, and -subunits of the mouse ENaC (32). Oocytes injected with
  mENaC cRNAs (3.3 ng/subunit) expressed an amiloride-sensitive whole-cell conductance of 75 ± 12 µS (Fig.
2). An amiloride-sensitive whole-cell
conductance was not observed in water-injected oocytes (data not
shown).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Functional expression of mENaCs in
Xenopus oocytes. Oocytes were injected with
  ENaC cRNAs (3.3 ng/subunit) and whole-cell conductances were
measured in the absence ( amiloride) or presence of 100 µM amiloride. Panel A shows a representative
response of whole-cell conductance and the response to amiloride.
Panel B shows representative current tracings obtained from
the voltage ramp protocol which were used to determine whole-cell
conductances. Solid line, control; broken line,
presence of amiloride. An amiloride-sensitive whole-cell conductance of
75 ± 12 µS was observed (panel C). Data are
expressed as the mean ± S.E. (n = 12).
|
|
Co-expression of ENaC and CFTR in Xenopus Oocytes--
It was
reported previously that co-expression of CFTR and ENaC in
Xenopus oocytes inhibited ENaC-mediated Na+
conductance (29, 33, 34). We used the oocyte expression system to
examine whether ENaCs regulate CFTR. Oocytes were co-injected with
human CFTR (10 ng) and mouse   ENaC (3.3 ng/subunit) cRNAs, and
whole-cell conductances were determined by two-electrode voltage clamp
(Fig. 3A). As shown in Fig.
3B, an amiloride-sensitive conductance of 81 ± 11 µS
was observed in the absence of forskolin/IBMX (n = 38).
However, after CFTR had been fully activated by forskolin/IBMX, no
amiloride-sensitive whole-cell conductance was observed (268 ± 29 µS pre-amiloride; 274 ± 29 µS, post-amiloride,
(n = 38); Fig. 3C). In addition, replacement
of Na+ with the impermeant cation NMDG in the bath solution
did not significantly affect the forskolin/IBMX-stimulated whole-cell conductance (241 ± 29 µS, Na+ bath; 261 ± 32 µS, NMDG bath (n = 9); Fig.
4), confirming the functional inhibition
of ENaC expression after CFTR activation, in agreement with
previous observations (29, 33, 34).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
Co-expression of hCFTR and mENaC in
Xenopus oocytes. Oocytes were injected with hCFTR
(10 ng) and   ENaC (3.3 ng/subunit) cRNAs, and whole-cell
conductances were measured in response to 100 µM
amiloride and to 10 µM forskolin with 100 µM IBMX. Panel A is a representative response
of the whole-cell conductance to amiloride and to forskolin/IBMX. The
additions of amiloride and of forskolin/IBMX to the bath solution are
indicated. Amiloride was washed out of the bath solution when oocytes
were initially exposed to IBMX and forskolin (+Fsk/IBMX). Amiloride was
added again to the bath solution at a later time (+Fsk/IBMX/amiloride).
Panel B shows representative current tracings obtained from
the voltage ramp protocol which were used to determine whole-cell
conductances. Solid line, control; short-dashed
line, +amiloride; dash-dotted line, +Fsk/IBMX;
long-dashed line, +Fsk/IBMX/amiloride. Before
activation of CFTR with forskolin/IBMX, the average change in
whole-cell conductance in response to amiloride was 81 ± 11 µS
(panel C). After stimulation with forskolin/IBMX (30 min),
no inhibition of whole-cell conductance was observed in response to
amiloride (panel D). The average forskolin/IBMX-stimulated
whole-cell conductance was 268 ± 29 µS before amiloride and
rose slightly to 274 ± 29 µS after the addition of 100 µM amiloride to the bath solution. Data are expressed as
the mean ± S.E. (n = 38).
|
|

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
Replacement of Na+
with the impermeant cation NMDG in the bath solution did not
alter forskolin/IBMX-activated whole-cell conductance.
Forskolin/IBMX-activated whole-cell conductances were measured in
oocytes injected with 10ng of CFTR cRNA or co-injected with CFTR and
  ENaC (3.3 ng/subunit). Replacement of NaCl (white
bars) in the bath solution with NMDG Cl (black bars)
did not significantly alter forskolin/IBMX-stimulated whole-cell
conductances (p > 0.2). Data are expressed as the
mean ± S.E. (n = 9).
|
|
Surprisingly, the forskolin/IBMX-stimulated whole-cell conductance in
oocytes co-injected with hCFTR and mENaC cRNAs (268 ± 29 µS)
was 3.7 times as large as that observed in oocytes injected with hCFTR
cRNA alone (73 ± 8 µS; n = 38;
p < 0.01; Fig. 5).
Additional experiments were performed to determine whether the
forskolin/IBMX-stimulated whole-cell conductance in oocytes co-injected
with hCFTR and mENaC cRNAs was mediated primarily by hCFTR. Replacement
of Cl with the impermeant anion
methanesulfonate (Fig. 6
(n = 10)) in the bath solution resulted in a
significant transient increase in the inward whole-cell current when
the voltage was clamped at a hyperpolarizing potential ( 50 mV). The
maximum increase of the inward current was achieved within 30 s
after ion replacement (data not shown). Furthermore, the
forskolin/IBMX-stimulated whole-cell conductance in oocytes co-injected
with hCFTR and mENaC cRNAs was blocked by 50 µM DPC (Fig.
7A (n = 10))
but was insensitive to 200 µM DIDS (Fig. 7B
(n = 10)). Taken together, these results indicate that
the forskolin/IBMX-stimulated conductance in oocytes co-injected with
hCFTR and   mENaC cRNAs was largely mediated by hCFTR
(35-37).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 5.
Forskolin/IBMX-activated conductances in
oocytes expressing hCFTR or co-expressing hCFTR and
  mENaC cRNAs.
Oocytes were injected with 10 ng of hCFTR cRNA or were co-injected with
10 ng of hCFTR cRNA and 10 ng of   mENaC (3.3 ng/subunit) cRNAs.
Whole-cell conductances were measured 30 min after the addition of 10 µM forskolin and 100 µM IBMX to the bath
solution. The forskolin/IBMX-stimulated whole-cell conductance in
oocytes co-injected with hCFTR and mENaC cRNAs (268 ± 29 µS)
was 3.7 times as large as that observed in oocytes injected with hCFTR
cRNA alone (73 ± 8 µS). Data are expressed as the mean ± S.E. (n = 38), p < 0.01.
|
|

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of anion substitution on
forskolin/IBMX-activated whole-cell currents. Oocytes were
injected with 10 ng of hCFTR or co-injected with 10 ng of hCFTR and 10 ng of   mENaC (3.3 ng/subunit). Whole-cell currents were
measured with the voltage clamped at a hyperpolarizing potential ( 50
mV) 30 min after the addition of 10 µM forskolin and 100 µM IBMX to the bath solution. Currents were measured in a
NaCl bath solution (white bars) and approximately 30 s
after perfusion of a solution in which NaCl was replaced with
Na+ methanesulfonate (black bars).
Significant increases in inward currents were observed in oocytes
expressing hCFTR alone when extracellular NaCl was replaced
Na+ methanesulfonate ( 4.3 ± 0.5 µA
(NaCl), 7.8 ± 0.9 µA (Na+
methanesulfonate ), n = 10, p < 0.005). Significant increases in inward currents
were also observed in oocytes co-expressing hCFTR and   mENaC,
when extracellular NaCl was replaced Na+
methanesulfonate ( 11.0 ± 1.1 µA (NaCl),
20.4 ± 1.8 µA (Na+
methanesulfonate ), n = 10, p < 0.001). Data are expressed as the mean ± S.E.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of anion channel inhibitors DPC or
DIDS on forskolin/IBMX-stimulated whole-cell conductances.
Xenopus oocytes were injected with 10 ng of hCFTR or
co-injected with 10 ng of hCFTR and 10 ng of   mENaC (3.3 ng/subunit). After stimulation with 10 µM forskolin and
100 µM IBMX (white bars, panel A), whole-cell
conductances were measured before and after the addition of 50 µM DPC (black bars; panel A) or 200 µM DIDS (panel B) to the bath solution.
Whole-cell conductances in oocytes expressing hCFTR (73.2 ± 5.7 µS ( DPC), 18.9 ± 6.2 µS (+DPC), n = 10, p < 0.01) or co-expressing hCFTR and   mENaC
cRNAs (269 ± 37 µS ( DPC), 56 ± 13 µS (+DPC),
n = 10, p < 0.01) were significantly
inhibited by 50 µM DPC. Whole-cell conductances in
oocytes expressing hCFTR (89.2 ± 12.5 µS ( DIDS), 85.2 ± 11.8 µS (+DIDS), n = 10, p > 0.2) or
co-expressing hCFTR and   mENaC cRNAs (241 ± 29 µS
( DIDS), 226 ± 23 µS (+DIDS), n = 10, p > 0.2) were not inhibited by 200 µM
DIDS. In panel B, the white bars indicate CFTR,
and the black bars indicate CFTR-ENaC. Data are expressed as
the mean ± S.E.
|
|
The enhancement of hCFTR Cl conductance observed when
hCFTR was co-expressed with   mENaC in Xenopus
oocytes was dependent on the amount of   mENaC cRNA injected.
Oocytes co-injected with 10 ng of hCFTR and 2 ng (0.67 ng/subunit) of
  mENaC cRNAs exhibited a forskolin/IBMX-stimulated conductance
(162 ± 27 µS; n = 8) that was only 1.6-fold
greater that the forskolin/IBMX-stimulated conductance observed in
oocytes injected with 10 ng of hCFTR alone (101 ± 19;
n = 8; p < 0.05, CFTR
versus CFTR/ENaC; Fig. 8).

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 8.
CFTR Cl conductance is enhanced
by   ENaC.
Xenopus oocytes were injected with 10 ng of hCFTR or
co-injected with 10 ng of hCFTR and 2 ng of   mENaC (0.67 ng/subunit). Whole-cell conductances were measured 30 min after the
addition of 10 µM forskolin and 100 µM IBMX
to the bath solution. Oocytes co-injected with hCFTR and   mENaC
cRNAs exhibited a forskolin/IBMX-stimulated conductance (162 ± 27 µS; n = 8) that was 1.6-fold greater than the
forskolin/IBMX-stimulated conductance observed in oocytes injected with
10 ng of hCFTR alone (101 ± 19; n = 8;
p < 0.05).
|
|
Analyses of hCFTR Single Channel Activity in Oocytes Injected with
hCFTR cRNA or Co-injected with hCFTR and   mENaC cRNAs--
The
forskolin/IBMX-stimulated hCFTR Cl conductance increased
significantly when hCFTR was co-expressed with   mENaC in
Xenopus oocytes compared with oocytes expressing hCFTR
alone. Increases in whole-cell hCFTR Cl conductance could
result from increases in hCFTR single channel conductance, hCFTR open
probability, or in the number of hCFTR Cl channels
expressed at the plasma membrane. Human CFTR single channel
Cl conductance was determined by cell-attached patch
clamp analyses of forskolin/IBMX-stimulated hCFTR Cl
channels expressed in the presence or absence of   mENaC.
Analyses of hCFTR single channel current/voltage relationships revealed similar slope conductances (6.7 pS (hCFTR) and 6.9 pS
(hCFTR/  mENaC)) (Fig. 9). Pipette
resistance was similar in both groups (30.0 ± 5.9 megohms (hCFTR,
n = 8); 35.1 ± 4.3 megohms (hCFTR/  mENaC, n = 9); p > 0.4). Eighteen hCFTR
Cl channels were observed in 16 patches in oocytes
injected with hCFTR alone, whereas 42 hCFTR Cl channels
were observed in 16 patches in oocytes co-expressing hCFTR and
  mENaC (p < 0.002), suggesting that the number
of hCFTR Cl channels expressed at the plasma membrane was
increased when hCFTR was co-expressed with   mENaC. The average
open probability was 0.11 ± 0.02 (n = 11) in
oocytes expressing hCFTR alone. This was significantly less than the
average open probability of 0.27 ± 0.04 (n = 10)
observed in oocytes co-expressing hCFTR and   mENaC (p < 0.004, hCFTR versus
hCFTR/  mENaC (Fig. 9D)). These data suggest that
increases in hCFTR Cl whole-cell conductance, when hCFTR
is co-expressed with   mENaC, occur in conjunction with an
increase in both hCFTR open probability and in the number of hCFTR
Cl channels expressed at the plasma membrane.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 9.
Analyses of CFTR Cl channels by
cell-attached patch clamp. Oocytes were injected with hCFTR cRNA
(panel A, left tracing) or co-injected with hCFTR
and   mENaC cRNAs (panel A, right
tracing). The pipette solution contained 96 mM NMDG
Cl. The closed state is as indicated in (c). Recordings were
performed at 90 mV. Panel B is a representative current
tracing from a patch containing multiple hCFTR Cl
channels in an oocyte co-injected with hCFTR and   mENaC cRNAs
(recording was performed at +90 mV to reduce brief channel closures
(channel flickering)). Multiple CFTR channels were observed in most
patches from oocytes co-injected with hCFTR and   mENaC cRNAs.
Panel C illustrates single CFTR Cl channel I/V
curves from oocytes injected with hCFTR cRNA alone (black
squares; n = 3-7 channels) or co-injected with
hCFTR and   mENaC cRNAs (black diamonds;
n = 4-8 channels). Holding potentials were increased
stepwise with a 30-mV increment from 90 mV to +90 mV. A linear
current voltage relationship was observed for both groups. Slope
conductances were 6.7 and 6.9 pS for hCFTR-injected and
hCFTR/  mENaC co-injected oocytes, respectively. hCFTR
Cl channel open probability was determined at holding
potentials of 60 mV and is illustrated in panel D. The
average open probability was 0.11 ± 0.02 (n = 11)
in oocytes expressing hCFTR alone and was 0.27 ± 0.04 (n = 10) in oocytes co-expressing hCFTR and
  mENaC (p < 0.004).
|
|
Effects of Individual mENaC Subunits on CFTR Cl
Conductance--
Epithelial Na+ channels are composed of
at least three structurally related subunits (38). Previous studies
demonstrated that amiloride-sensitive Na+ currents were
detectable in oocytes injected with ENaC cRNA, but at levels that
are ~100-fold less than Na+ currents observed in oocytes
injected with   ENaC cRNAs (38, 39). No detectable
amiloride-sensitive Na+ currents were observed in oocytes
injected with ENaC or ENaC cRNAs (38). We examined whether
co-expression of CFTR with individual ENaC subunit cRNAs altered the
levels of functional CFTR expression (Fig.
10). The forskolin/IBMX-stimulated
whole-cell conductance was 49 ± 10 µS in oocytes injected with
5 ng of hCFTR cRNA alone. The forskolin/IBMX-stimulated whole-cell
conductance increased to 109 ± 23 µS in oocytes co-injected
with 5 ng of hCFTR and of 5 ng mENaC cRNAs (p < 0.03, hCFTR versus hCFTR/ mENaC (n = 7)) and to 90 ± 16 µS in oocytes co-injected with hCFTR and
mENaC cRNAs (p < 0.05, hCFTR versus
hCFTR/ mENaC (n = 7)). These data suggested that
co-expression of hCFTR with individual mENaC subunits ( mENaC or
mENaC) enhanced functional hCFTR expression in Xenopus oocytes. Forskolin/IBMX-stimulated whole-cell conductances measured in
oocytes injected with hCFTR and mENaC cRNAs (62 ± 13 µS) or in oocytes injected with hCFTR cRNA alone were not significantly different (p > 0.2, hCFTR versus
hCFTR/ mENaC (n = 7)). These data suggest that the
enhancement of functional hCFTR expression by mENaC in
Xenopus oocytes is subunit-specific. Moreover, the absence
of an effect of mENaC on functional hCFTR expression suggested that
the functional activation of hCFTR by   mENaC or by selected
mENaC subunits is a specific effect and is not simply related to
co-injection of an irrelevant cRNA with hCFTR cRNA.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 10.
Forskolin/IBMX-activated whole-cell
conductances in oocytes expressing hCFTR or co-expressing hCFTR and
individual mENaC subunit cRNAs. Oocytes were injected with 5 ng of
hCFTR cRNA alone or co-injected with 5 ng of hCFTR and 5 ng of -,
-, or ENaC cRNA. Whole-cell conductances were measured 30 min
after the addition of 10 µM forskolin and 100 µM IBMX to the bath solution. The
forskolin/IBMX-stimulated whole-cell conductance in oocytes injected
with 5 ng of hCFTR cRNA was 49 ± 10 µS (n = 7).
The forskolin/IBMX-stimulated whole-cell conductance in oocytes
co-injected with hCFTR and mENaC cRNAs (109 ± 23 µS) was 2.2 times as large as that observed in oocytes injected with hCFTR cRNA
alone (n = 7, p < 0.03). The
forskolin/IBMX-stimulated whole-cell conductance was 90 ± 16 µS
in oocytes co-injected with 5 ng of hCFTR and of 5 ng of mENaC cRNAs
(n = 7, p < 0.05). Similar
forskolin/IBMX-stimulated whole-cell conductances were observed in
oocytes expressing hCFTR and co-expressing hCFTR and mENaC (62 ± 13 µS, n = 7, p > 0.2). Data are
expressed as mean ± S.E.
|
|
 |
DISCUSSION |
In addition to its primary function as a Cl channel,
CFTR functions as a regulator of several other epithelial ion channels (26, 40), including an outwardly rectifying Cl channel
(41-44), the epithelial Na+ channel (23-27, 29-31), and
a renal K+ channel (45-47). Through these interactions, it
appears that CFTR has an important role in regulation of the content
and volume of fluids in airways, intestines, pancreas, sweat ducts,
and renal tubules.
Our results confirm previous studies demonstrating that the functional
expression of CFTR is associated with an inhibition of functional ENaC
expression in Xenopus oocytes (25, 29, 34). The mechanisms
by which CFTR regulates ENaC are being defined. CFTR-mediated
inhibition of ENaC is associated with a decrease in Na+
channel open probability (16, 24, 30) and not with changes in levels of
ENaC mRNA or protein expression (8, 24). CFTR-mediated inhibition
of ENaC may involve autocrine or paracrine signaling and G
protein-coupled signaling mechanisms, changes in intracellular Cl concentration that may alter ENaC activity, or perhaps
direct interactions between CFTR and ENaC (25, 48, 49). The inhibition of ENaC by CFTR may be dependent on an intact first nucleotide binding
domain and does not require expression of a full-length CFTR protein
(33). The ability of CFTR mutants to transport Cl
correlates with their ability to inhibit ENaC; i.e. CFTR
mutants that express low levels of Cl currents in
Xenopus oocytes are inefficient in inhibiting functional expression of ENaC (34); however, CFTR-mediated inhibition of ENaC is
not necessarily dependent on the magnitude of Cl current
(29).
The present study demonstrates that interactions between the CFTR and
ENaC are more complex than suggested previously. The cAMP-regulated
conductance in oocytes co-expressing CFTR and ENaC was significantly
greater than that observed in oocytes expressing CFTR alone (Fig. 5),
in agreement with a recent observation by Chabot and co-workers (29).
This enhanced conductance observed in oocytes co-expressing CFTR and
ENaC was blocked by the CFTR inhibitor DPC (35, 37), was insensitive to
DIDS, a stilbene derivative that does not block CFTR but inhibits other
anion transporters (35, 36), and was not dependent on the presence of a
permeant extracellular cation (i.e. Na+, see
Figs. 4 and 7). These data suggest that this enhanced conductance in
forskolin/IBMX-stimulated oocytes co-expressing CFTR and ENaC is a
result of increased activity of CFTR Cl channels.
The increase in CFTR Cl conductance observed in oocytes
co-expressing   -mENaC was dependent on the amount of ENaC cRNA
injected into oocytes (Figs. 5 and 8). Co-expression of CFTR with
individual ENaC subunits enhanced Cl conductance but in a
subunit-specific manner (Fig. 10). An enhanced activation of CFTR
occurred with co-expression of either the - or -subunits of ENaC
but not with the subunit. This enhanced activation of CFTR observed
with individual - or -mENaC subunits (2.2- fold and 1.8-fold,
respectively) was considerably less than that observed with
  -mENaC (3.7-fold). The enhanced functional expression of CFTR
Cl channels which we observed with co-expression of ENaC
was not dependent on expression of functional Na+ channels.
Low levels of expression of amiloride-sensitive Na+
currents have been reported in Xenopus oocytes expressing
ENaC alone (38, 39), and no amiloride-sensitive Na+
currents have been observed in oocytes expressing ENaC alone (38).
When ENaC subunits are expressed individually in Xenopus oocytes, the subunits are found primarily within intracellular compartments (50). These results suggest that the co-expression of
individual ENaCs with CFTR might result in increased functional CFTR
expression by altering CFTR maturation or intracellular trafficking, leading to an enhanced cell surface expression of CFTR (see below).
An increase of CFTR Cl conductance was not observed in
oocytes co-expressing CFTR and ENaC, suggesting that specific
domains within the - or -subunits of ENaC are likely important in
conferring the ability of ENaC to regulate the functional expression of
CFTR. Consistent with this notion, previous work examining ENaC
interactions with CFTR using a yeast two-hybrid approach also suggested
that limited domains within ENaC were capable of binding CFTR
through its NBD1/R domain (25). Additional studies are needed to define the mechanism(s) by which - or ENaC alters functional CFTR
Cl channel expression.
The increase in the whole-cell CFTR Cl conductance
observed in oocytes co-expressing CFTR and ENaC reflects changes in one or more of the following variables: single channel conductance, open
probability, and the number of channels at the cell surface. Single
channel analyses of CFTR Cl channels indicated that CFTR
single channel conductances were nearly identical in oocytes expressing
CFTR alone and in oocytes co-expressing CFTR and ENaC (Fig. 9). The
open probability of CFTR Cl channels was increased
significantly when CFTR was co-expressed with   ENaC. However,
this 2.5-fold increase in CFTR Cl channel open
probability did not account for the 3.7-fold increase in whole-cell
conductance which we observed when CFTR Cl channels were
co-expressed with   ENaC, suggesting that the number of CFTR
Cl channels at the plasma membrane of the oocytes was
increased as well. Consistent with this notion, a significantly greater number of CFTR Cl channels was observed in cell-attached
patches of oocytes co-expressing CFTR and   ENaC (42 channels in
16 patches) than were observed in oocytes expressing CFTR alone (18 channels in 16 patches). Additional studies using biochemical
approaches to determine CFTR surface expression are needed to confirm
this observation and to determine mechanisms by which   ENaC
enhances plasma membrane expression of CFTR. Increases in levels of
plasma membrane expression of CFTR might arise from changes in CFTR
biosynthesis, maturation, recruitment to the plasma membrane, or
retrieval from the plasma membrane.
Although the concept that one ion channel species (i.e.
CFTR) regulates other ion channels is well established, it is unclear whether this phenomenon is broad or limited in scope. Coordinate regulation of Na+ and Cl transport proteins
in the apical plasma membrane of epithelia provides a mechanism by
which epithelial cells can modulate rates of NaCl reabsorption in
response to agonists. This is particularly important within selected
regions of the lung, sweat duct, salivary gland, and kidney sites where
epithelial cells reabsorb NaCl and express both ENaC and CFTR (19-22).
Protein kinase A-mediated activation of CFTR in epithelia expressing
both CFTR and ENaC results in increased transepithelial
Cl reabsorption as well as an inhibition of epithelial
Na+ channels as a result of reduced Na+ channel
open probability (16, 19-22, 24). In the absence of CFTR expression,
ENaC is activated by agonists that activate protein kinase A because of
increases in Na+ channel open probability or in the number
of channels expressed at the plasma membrane (16, 17, 24, 51). We
propose that the regulatory interactions between CFTR Cl
channels and epithelial Na+ channels provide a mechanism by
which selected epithelia can modulate net NaCl entry across the apical
membrane in response to agonists that would otherwise activate both
CFTR and ENaC. In this regard, an enhanced activity of CFTR might
augment CFTR-mediated inhibition of ENaC. These interactions provide a
cellular mechanism by which certain epithelia limit increases in cell
volume which might otherwise occur if CFTR and ENaC were activated in
parallel. In summary, our results indicate that, in addition to acting
as an ion channel and a regulator of other ion channels (including ENaC), CFTR activity is regulated by ENaC. Simply stated,
Na+ channels are not innocent bystanders; ENaCs are active
participants in this regulatory phenomenon.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Don-on Mak for help with
two-electrode voltage clamp experiments and related data analyses.
 |
FOOTNOTES |
*
This work was supported in part by grants from the Cystic
Fibrosis Foundation (to J. K. F. and T. R. K.) and by National
Institutes of Health Grant DK56305.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipients of postdoctoral fellowship awards from the Cystic
Fibrosis Foundation.
**
To whom correspondence should be addressed: Renal Division,
University of Pennsylvania, 700 CRB, 415 Curie Blvd., Philadelphia, PA
19104-6144. Tel.: 215-573-1848; Fax: 215-898-0189; E-mail: kleyman@mail.med.upenn.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
ENaC(s), epithelial
Na+ channel(s);
CF, cystic fibrosis;
CFTR, cystic fibrosis
transmembrane conductance regulator;
IBMX, 3-isobutyl-1-methylxanthine;
Vm, transmembrane potential;
I, transmembrane current;
NMDG, N-methyl-D-glucamine;
DPC, diphenylamine-2-carboxylic acid;
DIDS, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid;
Erev, reversal potential;
pS, picosiemens;
µS, microsiemens.
 |
REFERENCES |
| 1.
|
Nelson, W. J.
(1993)
Pediatr. Nephrol.
7,
599-604[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Wagner, M. C.,
and Molitoris, B. A.
(1999)
Pediatr. Nephrol.
13,
163-170[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Garty, H.,
and Palmer, L. G.
(1997)
Physiol. Rev.
77,
359-396[Abstract/Free Full Text]
|
| 4.
|
Benos, D. J.,
Awayda, M. S.,
Ismailov, I. I.,
and Johnson, J. P.
(1995)
J. Membr. Biol.
143,
1-18[Medline]
[Order article via Infotrieve]
|
| 5.
|
Palmer, L. G.,
and Frindt, G.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
2767-2770[Abstract/Free Full Text]
|
| 6.
|
Ciampolillo, F.,
McCoy, D. E.,
Green, R. B.,
Karlson, K. H.,
Dagenais, A.,
Molday, R. S.,
and Stanton, B. A.
(1996)
Am. J. Physiol.
271,
C1303-C1315[Abstract/Free Full Text]
|
| 7.
|
Duc, C.,
Farman, N.,
Canessa, C. M.,
Bonvalet, J. P.,
and Rossier, B. C.
(1994)
J. Cell Biol.
127,
1907-1921[Abstract/Free Full Text]
|
| 8.
|
Burch, L. H.,
Talbot, C. R.,
Knowles, M. R.,
Canessa, C. M.,
Rossier, B. C.,
and Boucher, R. C.
(1995)
Am. J. Physiol.
269,
C511-C518[Abstract/Free Full Text]
|
| 9.
|
Farman, N.,
Talbot, C. R.,
Boucher, R.,
Fay, M.,
Canessa, C.,
Rossier, B.,
and Bonvalet, J. P.
(1997)
Am. J. Physiol.
272,
C131-C141[Abstract/Free Full Text]
|
| 10.
|
Renard, S.,
Voilley, N.,
Bassilana, F.,
Lazdunski, M.,
and Barbry, P.
(1995)
Pflügers Arch. Eur. J. Physiol.
430,
299-307[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Begenisich, T.,
and Melvin, J. E.
(1998)
J. Membr. Biol.
163,
77-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Riordan, J. R.,
Rommens, J. M.,
Kerem, B.,
Alon, N.,
Rozmahel, R.,
Grzelczak, Z.,
Zielenski, J.,
Lok, S.,
Plavsic, N.,
Chou, J. L.,
Drumm, M. L.,
Iannuzzi, M. C.,
Collins, F. S.,
and Tsui, L.-C.
(1989)
Science
245,
1066-1073[Abstract/Free Full Text]
|
| 13.
|
Berger, H. A.,
Anderson, M. P.,
Gregory, R. J.,
Thompson, S.,
Howard, P. W.,
Maurer, R. A.,
Mulligan, R.,
Smith, A. E.,
and Welsh, M. J.
(1991)
J. Clin. Invest.
88,
1422-1431
|
| 14.
|
Pilewski, J. M.,
and Frizzell, R. A.
(1999)
Physiol. Rev.
79,
S215-S255
|
| 15.
|
Welsh, M. J.,
and Smith, A. E.
(1993)
Cell
73,
1251-1254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Stutts, M. J.,
Rossier, B. C.,
and Boucher, R. C.
(1997)
J. Biol. Chem.
272,
14037-14040[Abstract/Free Full Text]
|
| 17.
|
Marunaka, Y.,
and Eaton, D. C.
(1991)
Am. J. Physiol.
258,
C352-C368
|
| 18.
|
Chalfant, M. L.,
Coupaye-Gerard, B.,
and Kleyman, T. R.
(1993)
Am. J. Physiol.
264,
C1480-C1488[Abstract/Free Full Text]
|
| 19.
|
Stanton, B. A.
(1997)
Wien. Klin. Wochenschr.
109,
457-464[Medline]
[Order article via Infotrieve]
|
| 20.
|
Quinton, P. M.,
and Reddy, M. M.
(1994)
Jpn. J. Physiol.
44,
S207-S213
|
| 21.
|
Verrey, F.
(1994)
J. Membr. Biol.
138,
65-76[Medline]
[Order article via Infotrieve]
|
| 22.
|
Wine, J. J.
(1999)
J. Clin. Invest.
103,
309-312[Medline]
[Order article via Infotrieve]
|
| 23.
|
Ismailov, I. I.,
Awayda, M. S.,
Jovov, B.,
Berdiev, B. K.,
Fuller, C. M.,
Dedman, J. R.,
Kaetzel, M. A.,
and Benos, D. J.
(1996)
J. Biol. Chem.
271,
4725-4732[Abstract/Free Full Text]
|
| 24.
|
Ling, B. N.,
Zuckerman, J. B.,
Lin, C.,
Harte, B. J.,
McNulty, K. A.,
Smith, P. R.,
Gomez, L. M.,
Worrell, R. T.,
Eaton, D. C.,
and Kleyman, T. R.
(1997)
J. Biol. Chem.
272,
594-600[Abstract/Free Full Text]
|
| 25.
|
Kunzelmann, K.,
Kiser, G. L.,
Schreiber, R.,
and Riordan, J. R.
(1997)
FEBS Lett.
400,
341-344[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Schwiebert, E. M.,
Benos, D. J.,
Egan, M. E.,
Stutts, M. J.,
and Guggino, W. B.
(1999)
Physiol. Rev.
79,
S145-S166
|
| 27.
|
Stutts, M. J.,
Canessa, C. M.,
Olsen, J. C.,
Hamrick, M.,
Cohn, J. A.,
Rossier, B. C.,
and Boucher, R. C.
(1995)
Science
269,
847-850[Abstract/Free Full Text]
|
| 28.
|
Mall, M.,
Bleich, M.,
Kuehr, J.,
Brandis, M.,
Greger, R.,
and Kunzelmann, K.
(1999)
Am. J. Physiol.
277,
G709-G716[Abstract/Free Full Text]
|
| 29.
|
Chabot, H.,
Vives, M. F.,
Dagenais, A.,
Grygorczyk, C.,
Berthiaume, Y.,
and Grygorczyk, R.
(1999)
J. Membr. Biol.
169,
175-188[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Chinet, T. C.,
Fullton, J. M.,
Yankaskas, J. R.,
Boucher, R. C.,
and Stutts, M. J.
(1994)
Am. J. Physiol.
266,
C1061-C1068[Abstract/Free Full Text]
|
| 31.
|
Reddy, M. M.,
Light, M. J.,
and Quinton, P. M.
(1999)
Nature
402,
301-304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Ahn, Y. J.,
Brooker, D. R.,
Kosari, F.,
Harte, B. J.,
Li, J.,
Mackler, S. A.,
and Kleyman, T. R.
(1999)
Am. J. Physiol.
277,
F121-F129[Abstract/Free Full Text]
|
| 33.
|
Schreiber, R.,
Hopf, A.,
Mall, M.,
Greger, R.,
and Kunzelmann, K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
5310-5315[Abstract/Free Full Text]
|
| 34.
|
Briel, M.,
Greger, R.,
and Kunzelmann, K.
(1998)
J. Physiol. (Lond.)
508,
825-836[Abstract/Free Full Text]
|
| 35.
|
Schwiebert, E. M.,
Flotte, T.,
Cutting, G. R.,
and Guggino, W. B.
(1994)
Am. J. Physiol.
266,
C1464-C1477[Abstract/Free Full Text]
|
| 36.
|
Cliff, W. H.,
Schoumacher, R. A.,
and Frizzell, R. A.
(1992)
Am. J. Physiol.
262,
C1154-C1160[Abstract/Free Full Text]
|
| 37.
|
McCarty, N. A.,
McDonough, S.,
Cohen, B. N.,
Riordan, J. R.,
Davidson, N.,
and Lester, H. A.
(1993)
J. Gen. Physiol.
102,
1-23[Abstract/Free Full Text]
|
| 38.
|
Canessa, C. M.,
Schild, L.,
Buell, G.,
Thorens, B.,
Gautschi, I.,
Horisberger, J.-D.,
and Rossier, B. C.
(1994)
Nature
367,
463-467[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Canessa, C. M.,
Horisberger, J.-D.,
and Rossier, B. C.
(1993)
Nature
361,
467-470[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Greger, R.,
Mall, M.,
Bleich, M.,
Ecke, D.,
Warth, R.,
Riedemann, N.,
and Kunzelmann, K.
(1996)
J. Mol. Med.
74,
527-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Egan, M.,
Flotte, T.,
Afione, S.,
Solow, R.,
Zeitlin, P. L.,
Carter, B. J.,
and Guggino, W. B.
(1992)
Nature
358,
581-584[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Gabriel, S. E.,
Clarke, L. L.,
Boucher, R. C.,
and Stutts, M. J.
(1993)
Nature
363,
263-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Schwiebert, E. M.,
Egan, M. E.,
Hwang, T.-H.,
Fulmer, S. B.,
Allen, S. S.,
Cutting, G. R.,
and Guggino, W. B.
(1995)
Cell
81,
1063-1073[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Jovov, B.,
Ismailov, I. I.,
Berdiev, B. K.,
Fuller, C. M.,
Sorscher, E. J.,
Dedman, J. R.,
Kaetzel, M. A.,
and Benos, D. J.
(1995)
J. Biol. Chem.
270,
29194-29200[Abstract/Free Full Text]
|
| 45.
|
Ho, K.
(1998)
Curr. Opin. Nephrol. Hypertens.
7,
49-58[Medline]
[Order article via Infotrieve]
|
| 46.
|
McNicholas, C. M.,
Nason, M. W., Jr.,
Guggino, W. B.,
Schwiebert, E. M.,
Hebert, S. C.,
Giebisch, G.,
and Egan, M. E.
(1997)
Am. J. Physiol.
273,
F843-F848[Abstract/Free Full Text]
|
| 47.
|
McNicholas, C. M.,
Guggino, W. B.,
Schwiebert, E. M.,
Hebert, S. C.,
Giebisch, G.,
and Egan, M. E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
8083-8088[Abstract/Free Full Text]
|
| 48.
|
Cook, D. I.,
Dinudom, A.,
Komwatana, P.,
and Young, J. A.
(1998)
Eur. J. Morphol.
36 (suppl.),
67-73
|
| 49.
|
Ma, H.,
Bao, H.-F.,
Sun, J.,
Eaton, D. C.,
and Ling, B. N.
(1996)
J. Am. Soc. Nephrol.
7,
1284 (abstr.)
|
| 50.
|
Firsov, D.,
Schild, L.,
Gautschi, I.,
Merillat, A. M.,
Schneeberger, E.,
and Rossier, B. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15370-15375[Abstract/Free Full Text]
|
| 51.
|
Kleyman, T. R.,
Ernst, S. A.,
and Coupaye-Gerard, B.
(1994)
Am. J. Physiol.
266,
F506-F511[Abstract/Free Full Text]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Yaakov, E. Kerem, Y. Yahav, J. Rivlin, H. Blau, L. Bentur, M. Aviram, E. Picard, T. Bdolah-Abram, and M. Wilschanski
Reproducibility of Nasal Potential Difference Measurements in Cystic Fibrosis
Chest,
October 1, 2007;
132(4):
1219 - 1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Suaud, W. Yan, M. D. Carattino, A. Robay, T. R. Kleyman, and R. C. Rubenstein
Regulatory interactions of N1303K-CFTR and ENaC in Xenopus oocytes: evidence that chloride transport is not necessary for inhibition of ENaC
Am J Physiol Cell Physiol,
April 1, 2007;
292(4):
C1553 - C1561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Suaud, W. Yan, and R. C. Rubenstein
Abnormal regulatory interactions of I148T-CFTR and the epithelial Na+ channel in Xenopus oocytes
Am J Physiol Cell Physiol,
January 1, 2007;
292(1):
C603 - C611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Su, Q. Li, K. Shrestha, E. Cormet-Boyaka, L. Chen, P. R. Smith, E. J. Sorscher, D. J. Benos, S. Matalon, and H.-L. Ji
Interregulation of Proton-gated Na+ Channel 3 and Cystic Fibrosis Transmembrane Conductance Regulator
J. Biol. Chem.,
December 1, 2006;
281(48):
36960 - 36968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Reddy and P. M. Quinton
Cytosolic potassium controls CFTR deactivation in human sweat duct
Am J Physiol Cell Physiol,
July 1, 2006;
291(1):
C122 - C129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Goldfarb, O. B. Kashlan, J. N. Watkins, L. Suaud, W. Yan, T. R. Kleyman, and R. C. Rubenstein
Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels
PNAS,
April 11, 2006;
103(15):
5817 - 5822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bachhuber, J. Konig, T. Voelcker, B. Murle, R. Schreiber, and K. Kunzelmann
Cl- Interference with the Epithelial Na+ Channel ENaC
J. Biol. Chem.,
September 9, 2005;
280(36):
31587 - 31594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Nagel, P. Barbry, H. Chabot, E. Brochiero, K. Hartung, and R. Grygorczyk
CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes
J. Physiol.,
May 1, 2005;
564(3):
671 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-T. Chang, M. Bens, E. Hummler, S. Boulkroun, L. Schild, J. Teulon, B. C. Rossier, and A. Vandewalle
Vasopressin-stimulated CFTR Cl- currents are increased in the renal collecting duct cells of a mouse model of Liddle's syndrome
J. Physiol.,
January 1, 2005;
562(1):
271 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Yan, F. F. Samaha, M. Ramkumar, T. R. Kleyman, and R. C. Rubenstein
Cystic Fibrosis Transmembrane Conductance Regulator Differentially Regulates Human and Mouse Epithelial Sodium Channels in Xenopus Oocytes
J. Biol. Chem.,
May 28, 2004;
279(22):
23183 - 23192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.C. Boucher
New concepts of the pathogenesis of cystic fibrosis lung disease
Eur. Respir. J.,
January 1, 2004;
23(1):
146 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Suaud, M. Carattino, T. R. Kleyman, and R. C. Rubenstein
Genistein Improves Regulatory Interactions between G551D-Cystic Fibrosis Transmembrane Conductance Regulator and the Epithelial Sodium Channel in Xenopus Oocytes
J. Biol. Chem.,
December 20, 2002;
277(52):
50341 - 50347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-A. Konstas, J.-P. Koch, S. J. Tucker, and C. Korbmacher
Cystic Fibrosis Transmembrane Conductance Regulator-dependent Up-regulation of Kir1.1 (ROMK) Renal K+ Channels by the Epithelial Sodium Channel
J. Biol. Chem.,
July 5, 2002;
277(28):
25377 - 25384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bagorda, L. Guerra, F. Di Sole, C. Hemle-Kolb, R. A. Cardone, T. Fanelli, S. J. Reshkin, S. M. Gisler, H. Murer, and V. Casavola
Reciprocal Protein Kinase A Regulatory Interactions between Cystic Fibrosis Transmembrane Conductance Regulator and Na+/H+ Exchanger Isoform 3 in a Renal Polarized Epithelial Cell Model
J. Biol. Chem.,
June 7, 2002;
277(24):
21480 - 21488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Jentsch, V. Stein, F. Weinreich, and A. A. Zdebik
Molecular Structure and Physiological Function of Chloride Channels
Physiol Rev,
April 1, 2002;
82(2):
503 - 568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Suaud, J. Li, Q. Jiang, R. C. Rubenstein, and T. R. Kleyman
Genistein Restores Functional Interactions between Delta F508-CFTR and ENaC in Xenopus Oocytes
J. Biol. Chem.,
March 8, 2002;
277(11):
8928 - 8933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Broackes-Carter, N. Mouchel, D. Gill, S. Hyde, J. Bassett, and A. Harris
Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy
Hum. Mol. Genet.,
January 1, 2002;
11(2):
125 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-L. Ji, M. L. Chalfant, B. Jovov, J. P. Lockhart, S. B. Parker, C. M. Fuller, B. A. Stanton, and D. J. Benos
The Cytosolic Termini of the beta - and gamma -ENaC Subunits Are Involved in the Functional Interactions between Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel
J. Biol. Chem.,
September 1, 2000;
275(36):
27947 - 27956.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|